Soleno Therapeutics Inc (SLNO)
40.14
+2.60
(+6.93%)
USD |
NASDAQ |
Apr 23, 16:00
40.32
+0.18
(+0.46%)
Pre-Market: 20:00
Soleno Therapeutics Total Liabilities (Quarterly): 23.18M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 23.18M |
| September 30, 2023 | 40.33M |
| June 30, 2023 | 18.52M |
| March 31, 2023 | 16.90M |
| December 31, 2022 | 16.15M |
| September 30, 2022 | 16.78M |
| June 30, 2022 | 16.55M |
| March 31, 2022 | 16.08M |
| December 31, 2021 | 17.76M |
| September 30, 2021 | 22.36M |
| June 30, 2021 | 21.34M |
| March 31, 2021 | 19.14M |
| December 31, 2020 | 19.44M |
| September 30, 2020 | 23.78M |
| June 30, 2020 | 22.68M |
| March 31, 2020 | 22.63M |
| December 31, 2019 | 23.22M |
| September 30, 2019 | 13.84M |
| June 30, 2019 | 20.29M |
| March 31, 2019 | 15.24M |
| December 31, 2018 | 12.74M |
| Date | Value |
|---|---|
| September 30, 2018 | 16.63M |
| June 30, 2018 | 17.51M |
| March 31, 2018 | 13.31M |
| December 31, 2017 | 12.20M |
| September 30, 2017 | 3.172M |
| June 30, 2017 | 3.693M |
| March 31, 2017 | 3.721M |
| December 31, 2016 | 2.130M |
| September 30, 2016 | 2.597M |
| June 30, 2016 | 2.925M |
| March 31, 2016 | 3.556M |
| December 31, 2015 | 4.977M |
| September 30, 2015 | 8.579M |
| June 30, 2015 | 16.40M |
| March 31, 2015 | 21.37M |
| December 31, 2014 | 19.59M |
| September 30, 2014 | 44.07M |
| June 30, 2014 | 42.28M |
| March 31, 2014 | 39.72M |
| December 31, 2013 | 39.45M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.84M
Minimum
Sep 2019
40.33M
Maximum
Sep 2023
20.58M
Average
19.44M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Avid Bioservices Inc | 270.97M |
| Cassava Sciences Inc | 14.20M |
| United Therapeutics Corp | 1.182B |
| Creative Medical Technology Holdings Inc | 0.3714M |
| Viking Therapeutics Inc | 20.07M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 180.69M |
| Shareholders Equity (Quarterly) | 157.51M |